India’s Zydus, Lupin sign deal to co‑market Semaglutide injections
March 17 (Reuters) – Indian drugmakers Zydus Lifesciences and Lupin have signed a licensing and supply deal on…
The Highly Anticipated “Triple Agonist” Weight Loss Med Is Almost Here—What Doctors Say About It
This Medication May Lead to 28.7% Weight Loss Jarren Vink Eli Lilly just announced phase 3 clinical trial…